N'-(4,7-dimethoxy-1,3-benzothiazol-2-yl)-N,N-dimethylpropane-1,3-diamine, 95.0%, 250mg

AMONAFIDE, 97%, 100mg

2-Fluoro-n,4-dimethylaniline, 95%, 1g

1-Aminocyclobutanecarboxylic Acid Hydrochloride>98.0%(T)5g

3-Oxo-3-(4-trifluoromethylphenyl)propionic acid ethyl ester, 95.0%, 10g

2-(Furan-2-carboxamido)-3-(4-hydroxyphenyl)propionic acid, 250mg

1-(tert-Butyl) 2-methyl (2S,4S)-4-(hydroxymethyl)pyrrolidine-1,2-dicarboxylate, 98%, 250mg

Formaldehyde solution, 5 l

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)toluene, 98.0%, 25g

(S)-2-Benzylsuccinic acid, 95.0%, 100g

Sodium hypochlorite solution, 5-10% Cl, techn., 10 l, plastic packaging.

(R)-N-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-2-((S)-1-(N-hydroxyformamido)ethyl)-5-phenylpentanamide, 95%, 10mg

(1's,4'r)-4-(3,4-Difluorophenethyl)-4'-propyl-1,1'-bi(cyclohexane), 95.0%, 100mg